Sjalander, A., Jansson, J-H., Bergqvist, D., Eriksson, H., Carlberg, B., & Svensson. P. (2007). Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. Journal of Internal Medicine, 263. 52-60.
A meta-analysis of 10 randomized controlled trials.
Results: Lovenox prophylaxis prevents about 50% of expected venous thrombo-embolisms. Elevated risk of bleeding, although not significant. Death not significantly affected by Lovenox therapy.
Camporese, G., Bernardi, E., Prandoni, P., Noventa, F., Verlato, F., Simioni, P., et al. (2008). Low-molecular-weight heparin versus compression stockings for thrmoboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine, 149 (2), 73-82.
Assessor-blind, randomized, controlled trial.
Results: Lovenox found to be more effective in DVT prophylaxis than SCDs.
Buller, H., Angelli, G., Hull, R., Hyers, T., Prins, M. & Raskob, G. (2004). Antithrombotic therapy for venous thromboembolic disease: The seventh ACCP conference on antithrombotic and thrombolitic therapy. Chest Journal, 126 (3), 401S-428S.
Recommendations from the seventh conference of ACCP (American College of Chest Physicians).
Recommendations: For DVT prophylaxis, the use of both a heparin agent and elastic compression stockings is recommended, unless contraindicated.